Evidence map›Paper›PMID 42502720›Full record

ArticleJournal of pharmaceutical analysis2026

Drug delivery system of curcumin to the lungs based on poly(3-alloxyloxy-1,2-propylene succinate)-sebacic acid copolymers.

Karolina Knap, Konrad Kwiecień, Jonasz Czajkowski, Rafał Szostecki, Daria Niewolik, Katarzyna Jaszcz, Peter Olinga, Katarzyna Reczyńska-Kolman, Elżbieta Pamuła

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of pharmaceutical analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Karolina KnapDepartment of Biomaterials and Composites, Faculty of Materials Science and Ceramics, AGH University of Krakow, Kraków, 30-059, Poland.
Konrad KwiecieńDepartment of Biomaterials and Composites, Faculty of Materials Science and Ceramics, AGH University of Krakow, Kraków, 30-059, Poland.
Jonasz CzajkowskiDepartment of Biomaterials and Composites, Faculty of Materials Science and Ceramics, AGH University of Krakow, Kraków, 30-059, Poland.
Rafał SzosteckiDepartment of Biomaterials and Composites, Faculty of Materials Science and Ceramics, AGH University of Krakow, Kraków, 30-059, Poland.
Daria NiewolikDepartment of Physical Chemistry and Technology of Polymers, Faculty of Chemistry, Silesian University of Technology, Gliwice, 44-100, Poland.
Katarzyna JaszczDepartment of Physical Chemistry and Technology of Polymers, Faculty of Chemistry, Silesian University of Technology, Gliwice, 44-100, Poland.
Peter OlingaGroningen Research Institute of Pharmacy, Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, 9713 AV, the Netherlands.
Katarzyna Reczyńska-KolmanDepartment of Biomaterials and Composites, Faculty of Materials Science and Ceramics, AGH University of Krakow, Kraków, 30-059, Poland.
Elżbieta PamułaDepartment of Biomaterials and Composites, Faculty of Materials Science and Ceramics, AGH University of Krakow, Kraków, 30-059, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polyanhydrides are attractive materials for drug delivery matrices as a result of their cytocompatibility and fast degradation rate. Here, we synthesized and characterized copolymers of poly(3-allyloxy-1,2-propylene succinate) (PSAGE) and sebacic acid (SBA). The successful polymerization was confirmed by proton nuclear magnetic resonance (

Indexed as

CurcuminDrug delivery systemsMicroparticlesPolyanhydridesPulmonary delivery

Identifiers

PMID42502720
PMCPMC13400944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.